Lactitol

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Lactitol
Accession Number
DB12942
Type
Small Molecule
Groups
Investigational
Description

Lactitol has been used in trials studying the treatment of Bacterial Colonization.

Structure
Thumb
Synonyms
Not Available
External IDs
E-966 / INS NO.966 / INS-966 / NSC-231323
Categories
UNII
L2B0WJF7ZY
CAS number
585-86-4
Weight
Average: 344.3124
Monoisotopic: 344.13186161
Chemical Formula
C12H24O11
InChI Key
VQHSOMBJVWLPSR-JVCRWLNRSA-N
InChI
InChI=1S/C12H24O11/c13-1-4(16)7(18)11(5(17)2-14)23-12-10(21)9(20)8(19)6(3-15)22-12/h4-21H,1-3H2/t4-,5+,6+,7+,8-,9-,10+,11+,12-/m0/s1
IUPAC Name
(2S,3R,4R,5R)-4-{[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}hexane-1,2,3,5,6-pentol
SMILES
[H][C@](O)(CO)[C@@]([H])(O)[C@]([H])(O[C@]1([H])O[C@]([H])(CO)[C@]([H])(O)[C@]([H])(O)[C@@]1([H])O)[C@]([H])(O)CO

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteraction
AgmatineThe therapeutic efficacy of Lactitol can be decreased when used in combination with Agmatine.
Aluminum hydroxideThe therapeutic efficacy of Lactitol can be decreased when used in combination with Aluminum hydroxide.
AmilorideThe risk or severity of adverse effects can be increased when Amiloride is combined with Lactitol.
AmiodaroneThe therapeutic efficacy of Lactitol can be decreased when used in combination with Amiodarone.
AmitriptylineThe therapeutic efficacy of Lactitol can be decreased when used in combination with Amitriptyline.
AmlodipineThe therapeutic efficacy of Lactitol can be decreased when used in combination with Amlodipine.
AranidipineThe therapeutic efficacy of Lactitol can be decreased when used in combination with Aranidipine.
AtropineThe therapeutic efficacy of Lactitol can be decreased when used in combination with Atropine.
AzelnidipineThe therapeutic efficacy of Lactitol can be decreased when used in combination with Azelnidipine.
BarnidipineThe therapeutic efficacy of Lactitol can be decreased when used in combination with Barnidipine.
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
157355
PubChem Substance
347829086
ChemSpider
138481
ChEBI
75323
ChEMBL
CHEMBL1661
Wikipedia
Lactitol
ATC Codes
A06AD12 — Lactitol

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
2Unknown StatusTreatmentBacterial Colonization1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility377.0 mg/mLALOGPS
logP-3.2ALOGPS
logP-5.5ChemAxon
logS0.04ALOGPS
pKa (Strongest Acidic)12.1ChemAxon
pKa (Strongest Basic)-3ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count11ChemAxon
Hydrogen Donor Count9ChemAxon
Polar Surface Area200.53 Å2ChemAxon
Rotatable Bond Count8ChemAxon
Refractivity70.82 m3·mol-1ChemAxon
Polarizability31.98 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability0ChemAxon
Rule of FiveNoChemAxon
Ghose FilterNoChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
GC-MS Spectrum - GC-MS (9 TMS)GC-MSsplash10-0uxr-0793000000-953bf1e924fdd8f3400c
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as fatty acyl glycosides of mono- and disaccharides. These are compounds composed of a mono- or disaccharide moiety linked to one hydroxyl group of a fatty alcohol or of a phosphorylated alcohol (phosphoprenols), a hydroxy fatty acid or to one carboxyl group of a fatty acid (ester linkage) or to an amino alcohol.
Kingdom
Organic compounds
Super Class
Lipids and lipid-like molecules
Class
Fatty Acyls
Sub Class
Fatty acyl glycosides
Direct Parent
Fatty acyl glycosides of mono- and disaccharides
Alternative Parents
Alkyl glycosides / O-glycosyl compounds / Disaccharides / Fatty alcohols / Sugar alcohols / Oxanes / Secondary alcohols / Polyols / Oxacyclic compounds / Acetals
show 2 more
Substituents
Fatty acyl glycoside of mono- or disaccharide / Alkyl glycoside / Disaccharide / Glycosyl compound / O-glycosyl compound / Fatty alcohol / Sugar alcohol / Oxane / Secondary alcohol / Acetal
show 9 more
Molecular Framework
Aliphatic heteromonocyclic compounds
External Descriptors
disaccharide (CHEBI:75323)

Drug created on October 20, 2016 19:30 / Updated on August 02, 2018 06:45